Variable epitope library-based vaccines: shooting moving targets.

Area of Science:

• Immunology
• Vaccinology
• Molecular Biology

Background:

• Antigenic variability is a major challenge for vaccines against pathogens and cancer.
• Current vaccine strategies inadequately address antigenic variability.
• Developing vaccines for antigenically variable pathogens (AVPs) requires novel approaches.

Purpose of the Study:

• To develop and validate a novel variable epitope library (VEL)-based vaccine strategy.
• To assess the breadth, potency, and durability of immune responses induced by VEL immunogens.
• To investigate immune interference mechanisms in response to variable epitopes.

Main Methods:

• Constructed immunogens using plasmid DNA and M13 bacteriophages displaying epitope variants.
• Generated combinatorial libraries with random amino acid substitutions in an HIV-1 epitope.
• Assessed CD8+ T-cell responses, T-cell proliferation, and FACS analysis in immunized mice.

Main Results:

• Immunization with VELs induced potent, broad, and long-lasting CD8+ T-cell responses recognizing >50% of mutated variants.
• Effector memory T cells were induced, with responses sustained for 12 months.
• Demonstrated inhibition of T-cell responses by immune interference after sequential immunization.

Conclusions:

• The VEL-based strategy is a promising technological platform for vaccines against AVPs and cancer.
• Findings offer mechanistic insights into vaccine trial failures and hurdles in molecular vaccine design.
• This approach enhances understanding of host-pathogen interactions in the context of antigenic variability.